Results 141 to 150 of about 3,238 (182)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases. [PDF]

Japanese Journal of Clinical Oncology, 2016
Oligometastases can be divided into sync-oligometastases and oligo-recurrence. The difference is whether the primary site is uncontrolled or controlled. The goal of this multicenter study was to evaluate treatment outcomes and factors affecting survival after stereotactic body radiotherapy for pulmonary oligometastases.The information after ...
Hideomi Yamashita, Kuniaki Katsui, Keiichi Nakagawa   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Oligometastases revisited

Nature Reviews Clinical Oncology, 2011
We previously proposed a clinical state of metastasis termed 'oligometastases' that refers to restricted tumor metastatic capacity. The implication of this concept is that local cancer treatments are curative in a proportion of patients with metastases.
Ralph Weichselbaum
exaly   +3 more sources

Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance

Physics and Imaging in Radiation Oncology, 2019
Background and purpose: Recent studies have shown that the use of magnetic resonance (MR) guided online plan adaptation yields beneficial dosimetric values and reduces unplanned violations of the dose constraints for stereotactic body radiation therapy ...
Petra Kroon, Bram van Asselen, Martijn Intven   +2 more
exaly   +3 more sources

Oligometastases: Emerging Evidence

Journal of Clinical Oncology, 2022
The hypothesis that ablative therapies (such as surgery or radiation) can be used to cure patients with a limited number of metastases was influential in changing practice. Early assertions of efficacy were based on observational studies, often without control groups, showing better-than-expected outcomes.
Wei Liu, Houda Bahig, David A. Palma
openaire   +2 more sources

Esophageal Oligometastases of the Foot

Clinical Nuclear Medicine, 2022
Abstract Acrometastasis is a rare clinical entity, estimated to represent less than 0.3% of all bone metastases. Here, we present a case of esophageal cancer that was treated with esophagectomy, chemotherapy, and radiation therapy and developed oligometastases of the foot after 8 years in remission.
John M, Ricely, David, Posocco, Simin, Dadparvar   +2 more
openaire   +2 more sources

Stereotactic body radiation therapy for oligometastases

Expert Review of Anticancer Therapy, 2009
The standard treatment for metastatic cancer is systemic therapy. However, in a subset of patients with limited extracranial metastases or oligometastases, local ablative therapy in combination with systemic therapy may improve treatment outcomes.
Higinia Cardenes, Jian Z Wang, Lech Papież   +2 more
exaly   +3 more sources

Physics and Imaging for Targeting of Oligometastases

Seminars in Radiation Oncology, 2006
Oligometastases refer to metastases that are limited in number and location and are amenable to regional treatment. The majority of these metastases appear in the brain, lung, liver, and bone. Although the focus of interest in the past within radiation oncology has been on the treatment of intracranial metastases, there has been growing interest in ...
Fang-Fang, Yin, Shiva, Das, John, Kirkpatrick, Mark, Oldham, Zhiheng, Wang, Su-Min, Zhou   +5 more
openaire   +2 more sources

Radiotherapy in the management of lung oligometastases

Cancer/Radiothérapie
In recent years, the development of both medical imaging and new systemic agents (targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to a new entity: oligometastatic disease. Adding local treatment of oligometastases to systemic treatment could lead to prolonged survival with no significant impact on quality of life.
Bourbonne, V., Lévy, A., Khalifa, J., Antoni, D., Blais, E., Darréon, J., Le Péchoux, C., Lerouge, D., Giraud, P., Marguerit, A., Pourel, N., Riet, F.-G., Thureau, S.   +12 more
openaire   +3 more sources

Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?

Radiotherapy and Oncology, 2013
Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease (OMD), but there are no studies comparing SABR with pulmonary metastasectomy (PME). We analysed consecutive patients referred via a university-hospital based multidisciplinary team.Patients were offered ...
Widder, Joachim, Klinkenberg, Theo J., Ubbels, Jan F., Wiegman, Erwin M., Groen, Harry J. M., Langendijk, Johannes A.   +5 more
openaire   +3 more sources

Treatment of Oligometastases After Successful Immunotherapy

Seminars in Radiation Oncology, 2006
Local destruction of individual metastases by any of a number of effective modalities fails as a treatment for most patients with disseminated cancer because of the presence of either undetected micrometastases or simply too many lesions. The availability of a systemic therapy that could reduce the number of metastases to a manageable few would ...
James C, Yang, John, Abad, Richard, Sherry   +2 more
openaire   +2 more sources